UNSPSC 51422305: Desoximetasone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29FO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4E07GXB7AU, chemically known as 9-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione but generally known as desoximetasone, which bears US NIH Compound Identifier 9793. European Medicines Agency schedules Desoximetasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07006MIG.

UNSPSC 51422305 Desoximetasone is a Commodity code for a specific corticosteroid pharmaceutical, but the recent state and local opportunities tagged under it show no procurement activity aligned with the code's nominal scope. The two posted opportunities—one from Seminole County, Florida seeking naloxone and drug deactivation systems, and one from the Texas Health and Human Services Commission requesting information on direct-to-manufacturer prescription programs—do not match desoximetasone procurement. State and local governments acquire desoximetasone primarily through standing health department contracts, managed care organization formulary agreements, and group purchasing organization (GPO) vehicles serving public health clinics and correctional health programs, but the recent-opportunities block contains no solicitations for desoximetasone itself.

The code shows minimal recent procurement activity. No state or local issuing bodies have posted RFP, RFQ, IFB, or ITB notices specifically for desoximetasone in the sourced period. When state and local agencies do procure this topical corticosteroid, they typically bundle it within broader pharmaceutical supply contracts rather than solicit it as a standalone line item. Unless your firm focuses on pharmaceutical distribution to state Medicaid programs, public correctional facilities, or health departments through GPO channels, this code does not represent an active pursuit opportunity at present.